Zhengrong Cui1, Uyen M Le, Fu Qiu, Dalia S Shaker. 1. Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, OR 97331, USA. zhengrong.cui@oregonstate.edu
Abstract
PURPOSE: Coaxing dead tumor cells to induce specific immune responses is an attractive tumor therapy. However, there continues to be a need for adjuvants that can promote the cross-presentation of the dead tumor cells to induce specific anti-tumor response. Viral dsRNA has multiple mechanisms to promote the cross-presentation of viral antigens in virus-infected cells. We propose to learn from viruses by generating dead tumor cells having synthetic dsRNA delivered inside them to allow the dsRNA to promote the cross-presentation of dead tumor cells. MATERIALS AND METHODS: Using synthetic dsRNA, poly(I:C), and the TC-1 cervical cancer model, we evaluated the extent to which the poly(I:C) can promote the necrotic bodies of TC-1 cells to induce specific anti-tumor immune response. The poly(I:C) was either simply mixed with the dead TC-1 cells or pre-loaded inside them. RESULTS: Immunization of tumor-bearing mice with the necrotic bodies of tumor cells admixed with poly(I:C) significantly inhibited the tumor growth. More importantly, immunization with the necrotic bodies having poly(I:C) pre-loaded inside led to a significantly stronger anti-tumor response than when the necrotic bodies were simply admixed with the poly(I:C), apparently through a CD8(+) CTL response-mediated mechanism. CONCLUSIONS: These findings are expected to be clinically relevant for devising improved whole cell-based tumor vaccines.
PURPOSE: Coaxing dead tumor cells to induce specific immune responses is an attractive tumor therapy. However, there continues to be a need for adjuvants that can promote the cross-presentation of the dead tumor cells to induce specific anti-tumor response. Viral dsRNA has multiple mechanisms to promote the cross-presentation of viral antigens in virus-infected cells. We propose to learn from viruses by generating dead tumor cells having synthetic dsRNA delivered inside them to allow the dsRNA to promote the cross-presentation of dead tumor cells. MATERIALS AND METHODS: Using synthetic dsRNA, poly(I:C), and the TC-1 cervical cancer model, we evaluated the extent to which the poly(I:C) can promote the necrotic bodies of TC-1 cells to induce specific anti-tumor immune response. The poly(I:C) was either simply mixed with the dead TC-1 cells or pre-loaded inside them. RESULTS: Immunization of tumor-bearing mice with the necrotic bodies of tumor cells admixed with poly(I:C) significantly inhibited the tumor growth. More importantly, immunization with the necrotic bodies having poly(I:C) pre-loaded inside led to a significantly stronger anti-tumor response than when the necrotic bodies were simply admixed with the poly(I:C), apparently through a CD8(+) CTL response-mediated mechanism. CONCLUSIONS: These findings are expected to be clinically relevant for devising improved whole cell-based tumor vaccines.
Authors: N Fujita; H Kagamu; H Yoshizawa; K Itoh; H Kuriyama; N Matsumoto; T Ishiguro; J Tanaka; E Suzuki; H Hamada; F Gejyo Journal: J Immunol Date: 2001-11-15 Impact factor: 5.422
Authors: Kerstin N Schmidt; Beatrice Leung; Mandy Kwong; Kol A Zarember; Sanjeev Satyal; Tony A Navas; Fay Wang; Paul J Godowski Journal: J Immunol Date: 2004-01-01 Impact factor: 5.422
Authors: Y L Yang; L F Reis; J Pavlovic; A Aguzzi; R Schäfer; A Kumar; B R Williams; M Aguet; C Weissmann Journal: EMBO J Date: 1995-12-15 Impact factor: 11.598
Authors: B Leticia Rodriguez; Jorge M Blando; Dharmika S P Lansakara-P; Yuriko Kiguchi; John DiGiovanni; Zhengrong Cui Journal: Mol Pharm Date: 2013-05-17 Impact factor: 4.939
Authors: Eva Lion; Sébastien Anguille; Zwi N Berneman; Evelien L J M Smits; Viggo F I Van Tendeloo Journal: PLoS One Date: 2011-06-17 Impact factor: 3.240